{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:14:38Z","timestamp":1767831278398,"version":"3.49.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1093\/carcin\/bgq033","type":"journal-article","created":{"date-parts":[[2010,1,30]],"date-time":"2010-01-30T02:08:31Z","timestamp":1264817311000},"page":"745-750","source":"Crossref","is-referenced-by-count":142,"title":["Epigenetic inactivation of the miR-34a in hematological malignancies"],"prefix":"10.1093","volume":"31","author":[{"given":"C.S.","family":"Chim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.Y.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Loong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.L.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.G.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.Y.","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.F.","family":"Costello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2010,1,29]]},"reference":[{"key":"key\n\t\t\t\t20170520222920_bib1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/hon.694","article-title":"Hypermethylation of gene promoters in hematological neoplasia","volume":"20","author":"Chim","year":"2002","journal-title":"Hematol. Oncol."},{"key":"key\n\t\t\t\t20170520222920_bib2","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1056\/NEJMra023075","article-title":"Gene silencing in cancer in association with promoter hypermethylation","volume":"349","author":"Herman","year":"2003","journal-title":"N Engl J Med."},{"key":"key\n\t\t\t\t20170520222920_bib3","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1200\/JCO.2001.19.7.2033","article-title":"Methylation of p15 and p16 genes in acute promyelocytic leukemia: potential diagnostic and prognostic significance","volume":"19","author":"Chim","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"key\n\t\t\t\t20170520222920_bib4","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1046\/j.1365-2141.2003.04462.x","article-title":"Aberrant gene promoter methylation in acute promyelocytic leukaemia: profile and prognostic significance","volume":"122","author":"Chim","year":"2003","journal-title":"Br. J. Haematol."},{"key":"key\n\t\t\t\t20170520222920_bib5","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3816\/CLM.2008.n.048","article-title":"Gene hypermethylation in multiple myeloma: lessons from a cancer pathway approach","volume":"8","author":"Chim","year":"2008","journal-title":"Clin. lymphoma myeloma"},{"key":"key\n\t\t\t\t20170520222920_bib6","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1038\/sj.leu.2404939","article-title":"Epigenetic dysregulation of Wnt signaling pathway in multiple myeloma","volume":"21","author":"Chim","year":"2007","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t20170520222920_bib7","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/jcp.2006.038331","article-title":"Epigenetic dysregulation of the death-associated protein kinase\/p14\/HDM2\/p53\/Apaf-1 apoptosis pathway in multiple myeloma","volume":"60","author":"Chim","year":"2007","journal-title":"J. Clin. Pathol."},{"key":"key\n\t\t\t\t20170520222920_bib8","doi-asserted-by":"crossref","first-page":"4630","DOI":"10.1182\/blood-2003-06-2007","article-title":"SOCS1 and SHP1 hypermethylation in multiple myeloma: implications for epigenetic activation of the Jak\/STAT pathway","volume":"103","author":"Chim","year":"2004","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170520222920_bib9","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00277-004-0843-1","article-title":"Epigenetic dysregulation of the Jak\/STAT pathway by frequent aberrant methylation of SHP1 but not SOCS1 in acute leukaemias","volume":"83","author":"Chim","year":"2004","journal-title":"Ann. Hematol."},{"key":"key\n\t\t\t\t20170520222920_bib10","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1038\/sj.leu.2403133","article-title":"Disruption of INK4\/\/CDK\/\/Rb cell cycle pathway by gene hypermethylation in multiple myeloma and MGUS","volume":"17","author":"Chim","year":"2003","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t20170520222920_bib11","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/sj.leu.2404205","article-title":"Aberrant gene promoter methylation marking disease progression in multiple myeloma","volume":"20","author":"Chim","year":"2006","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t20170520222920_bib12","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrc1997","article-title":"MicroRNA signatures in human cancers","volume":"6","author":"Calin","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"key\n\t\t\t\t20170520222920_bib13","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/humu.10190","article-title":"TP53 in hematological cancer: low incidence of mutations with significant clinical relevance","volume":"21","author":"Peller","year":"2003","journal-title":"Hum. Mutat."},{"key":"key\n\t\t\t\t20170520222920_bib14","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.4161\/cc.7.16.6533","article-title":"Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer","volume":"7","author":"Lodygin","year":"2008","journal-title":"Cell Cycle"},{"key":"key\n\t\t\t\t20170520222920_bib15","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2141.1976.tb03563.x","article-title":"Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group","volume":"33","author":"Bennett","year":"1976","journal-title":"Br. J. Haematol."},{"key":"key\n\t\t\t\t20170520222920_bib16","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-2141.1988.tb04242.x","article-title":"(1988) Second MIC Cooperative Study Group. Morphologic, immunologic and cytogenetic (MIC) working classification of the acute myeloid leukaemias","volume":"68","journal-title":"Br. J. Haematol."},{"key":"key\n\t\t\t\t20170520222920_bib17","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1182\/blood-2007-06-093906","article-title":"International Workshop on Chronic Lymphocytic Leukemia. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines","volume":"111","author":"Hallek","year":"2008","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170520222920_bib18","volume-title":"WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. 4th edn","author":"Swerdlow","year":"2008"},{"key":"key\n\t\t\t\t20170520222920_bib19","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.molcel.2007.05.010","article-title":"Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis","volume":"26","author":"Chang","year":"2007","journal-title":"Mol. Cell"},{"key":"key\n\t\t\t\t20170520222920_bib20","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.4161\/cc.6.13.4436","article-title":"Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest","volume":"6","author":"Tarasov","year":"2007","journal-title":"Cell Cycle"},{"key":"key\n\t\t\t\t20170520222920_bib21","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.4161\/cc.6.12.4408","article-title":"CpG hypermethylation of tumor suppressor microRNAs in human cancer","volume":"6","author":"Lujambio","year":"2007","journal-title":"Cell Cycle"},{"key":"key\n\t\t\t\t20170520222920_bib22","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1182\/blood-2003-05-1401","article-title":"Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index","volume":"103","author":"Chim","year":"2004","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170520222920_bib23","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1046\/j.1365-2141.2003.04396.x","article-title":"Aberrant promoter CpG methylation as a molecular marker for disease monitoring in natural killer cell lymphomas","volume":"122","author":"Siu","year":"2003","journal-title":"Br. J. Haematol."},{"key":"key\n\t\t\t\t20170520222920_bib24","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.4161\/cc.7.24.7245","article-title":"Chronic lymphocytic leukemia and treatment resistance in cancer: the role of the p53 pathway","volume":"7","author":"Zenz","year":"2008","journal-title":"Cell Cycle"},{"key":"key\n\t\t\t\t20170520222920_bib25","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/(SICI)1098-1004(200001)15:1<105::AID-HUMU19>3.0.CO;2-G","article-title":"p53 website and analysis of p53 gene mutations in human cancer: forging a link between epidemiology and carcinogenesis","volume":"15","author":"Soussi","year":"2000","journal-title":"Hum. Mutat."},{"key":"key\n\t\t\t\t20170520222920_bib26","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","article-title":"Genomic aberrations and survival in chronic lymphocytic leukemia","volume":"343","author":"D\u00f6hner","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"key\n\t\t\t\t20170520222920_bib27","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1007\/s10038-006-0029-x","article-title":"Frequent DAP kinase but not p14 or Apaf-1 hypermethylation in B-cell chronic lymphocytic leukemia","volume":"51","author":"Chim","year":"2006","journal-title":"J. Hum. Genet."},{"key":"key\n\t\t\t\t20170520222920_bib28","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1158\/0008-5472.CAN-08-0325","article-title":"Epigenetic silencing of MicroRNA-34b\/c and B-Cell translocation gene 4 is associated with CpG island methylation in colorectal cancer","volume":"68","author":"Toyota","year":"2008","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20170520222920_bib29","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1200\/JCO.1997.15.10.3280","article-title":"Karnofsky Memorial Lecture. Hereditary cancer: theme and variations","volume":"15","author":"Knudson","year":"1997","journal-title":"J. Clin. Oncol."},{"key":"key\n\t\t\t\t20170520222920_bib30","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1038\/sj.bjc.6690234","article-title":"Loss of heterozygosity at chromosome 1p in different solid human tumours: association with survival","volume":"79","author":"Ragnarsson","year":"1999","journal-title":"Br. J. Cancer"},{"key":"key\n\t\t\t\t20170520222920_bib31","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1038\/sj.bjc.6604032","article-title":"Genetic and epigenetic changes in the common 1p36 deletion in neuroblastoma tumours","volume":"97","author":"Caren","year":"2007","journal-title":"Br. J. Cancer"},{"key":"key\n\t\t\t\t20170520222920_bib32","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1182\/blood.V92.9.3405","article-title":"Chromosome band 1p36 contains a putative tumor suppressor gene important in the evolution of chronic myelocytic leukemia","volume":"92","author":"Mori","year":"1998","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170520222920_bib33","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1046\/j.1365-2141.2003.04434.x","article-title":"Progression of myelodysplastic syndrome: allelic loss on chromosomal arm 1p","volume":"122","author":"Naoki","year":"2003","journal-title":"Br. J. Haematol."},{"key":"key\n\t\t\t\t20170520222920_bib34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ijc.10618","article-title":"Frequent inactivation of the p73 gene by abnormal methylation or LOH in non-Hodgkin's lymphomas","volume":"102","author":"Beatriz","year":"2002","journal-title":"Int. J. Cancer"},{"key":"key\n\t\t\t\t20170520222920_bib35","doi-asserted-by":"crossref","first-page":"6936","DOI":"10.1038\/sj.onc.1209996","article-title":"Expression of p53 and p53\/\/47 are controlled by alternative mechanisms of messenger RNA translation initiation","volume":"25","author":"Candeias","year":"2006","journal-title":"Oncogene"}],"container-title":["Carcinogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/carcin\/article-pdf\/31\/4\/745\/17288474\/bgq033.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T05:00:40Z","timestamp":1590555640000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/carcin\/article-lookup\/doi\/10.1093\/carcin\/bgq033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,29]]},"references-count":35,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2010,1,29]]},"published-print":{"date-parts":[[2010,4]]}},"URL":"https:\/\/doi.org\/10.1093\/carcin\/bgq033","relation":{},"ISSN":["1460-2180","0143-3334"],"issn-type":[{"value":"1460-2180","type":"electronic"},{"value":"0143-3334","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1,29]]}}}